glp 1 drugs and breast cancer GLP-1 Receptor Agonists in Cancer: A New Frontier in Obesity Prognosis Management GLP-1 Drugs May Improve Breast

including prescribing and dispensing medication (indicates whether the patient picked up the medication) trends

In findings presented at the American Diabetes Association Scientific Sessions and simultaneously published in T he New England Journal of Medicine , most adults receiving 24 mg or more per day of the oral GLP-1 orforglipron (Eli Lilly) lost 10% or more of their body weight at 36 weeks, and weight loss approached 15% at 36 weeks in the highest dose group

Chin J Liver Dis 2021;13:46-53

If you need long-term prokinetic therapy, GLP-1 medications might not be the best fit

A standard multivitamin within RDA limits may be considered if dietary intake is insufficient, but supplements should ideally target confirmed deficiencies identified through blood tests

This raises concerns about the risk of patients taking GLP-1 medications choking while under anaesthesia during surgery